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A B S T R A C T
Here we describe a method for robust directed evolution using mutagenesis of large sequence spaces in their genomic contexts. The method employs error-prone PCR
and Cas9-mediated genome integration of mutant libraries of large-sized donor variants into single or multiple genomic sites with eﬃciencies reaching 98–99%. From
sequencing of genome integrants, we determined that the mutation frequency along the donor fragments is maintained evenly and successfully integrated into the
genomic target loci, indicating that there is no bias of mutational load towards the proximity of the double strand break. To validate the applicability of the method
for directed evolution of metabolic gene products we engineered two essential enzymes in the mevalonate pathway of Saccharomyces cerevisiae with selected variants
supporting up to 11-fold higher production of isoprenoids. Taken together, our method extends on existing CRISPR technologies by facilitating eﬃcient mutagenesis
of hundreds of nucleotides in cognate genomic contexts.
1. Introduction
Directed evolution is a powerful approach and has been extensively
used for functional analysis and optimization of DNA sequences, gene
functions and protein structures (Buller et al., 2015; Jeschek et al.,
2016). In order to employ directed evolution, both the strategy for
creating mutant libraries, as well as the assays for screening and se-
lection of improved variants in high throughput, need to be considered
(DeLoache et al., 2015; Körfer et al., 2016; Wong et al., 2004). Nowa-
days, methods for generation of sequence-variant libraries often include
custom-designed DNA oligo library pools, multiplexed oligo assembly,
or more or less randomized mutagenesis of template DNA fragments
(Mutalik et al., 2013; Plesa et al., 2018; Yang et al., 2017). Screening
and selection assays based on conditional growth, genetically-encoded
biosensors, and reporter gene activities, has recently been applied to
complement the eﬃciency of library generation (Lee et al., 2013;
Mundhada et al., 2016; Raman et al., 2014; Skjoedt et al., 2016). Ir-
respective of the origin of input library and the screening assays ap-
plied, when aiming to infer functional consequences of regulatory or
genic DNA variants, it is important to acknowledge the impact of gene
dosage and the genomic context of the gene encoding the protein of
interest, as both overexpression and epigenetic regulation can impact
downstream regulation arising from genetic variants when expressed
from non-native plasmid-based cassettes or when using heterologous
promoters (Gibson et al., 2013). For this reason, targeted genome in-
tegration of diversiﬁed templates should be the preferred tactic for
directed evolution. However, in order to harness the power of directed
evolution in deﬁned genomic contexts it is important to evaluate the
capacity for living cells to take up and genomically integrate large,
heterologous DNA fragments.
Pioneering studies on integration of linear fragments with homo-
logous ends to chromosome integration sites was performed in yeast
more than three decades ago (Orr-Weaver et al., 1981; Resnick and
Martin, 1976; Szostak et al., 1983). Since then, the use of inducible
endonucleases targeting deﬁned genomic loci has further developed
and improved both HR-based in vivo assembly of DNA fragments and
methods for genome integration of heterologous DNA in both yeast and
mammalian cells (Kuijpers et al., 2013; Rouet et al., 1994; Storici et al.,
2001; Storici and Resnick, 2003). As such, the use of endonucleases has
been reported to increase integration eﬃciencies by several orders of
magnitude (Storici and Resnick, 2003). More recently, the use of the
type II CRISPR/Cas9 system from Streptococcus pyogenes has gained
broad adoption for RNA-guided gene editing and genome engineering
in a wide range of organisms (Cong et al., 2013; DiCarlo et al., 2013;
Jakočiūnas et al., 2017, 2016; Li et al., 2015). Cas9 is an RNA-guided
endonuclease that introduces double-stranded breaks (DSBs) at almost
any target DNA locus where a protospacer-adjacent motif (PAM; NGG)
is present, yielding several hundred thousand genomic target sites in an
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average eukaryotic genome (DiCarlo et al., 2013). With the ability to
target and integrate heterologous DNA fragments at high eﬃciencies by
way of homologous recombination, several studies have investigated
directed evolution and sequence-function relationships of regulatory
and genic regions in genomic contexts, albeit using short oligonucleo-
tides as repair donors (Barbieri et al., 2017; Findlay et al., 2014; Garst
et al., 2017; Storici et al., 2001; Wang et al., 2009). In addition, larger
mutagenized DNA fragments were in vivo assembled and integrated
into the S. cerevisiae genome by employing Cas9 and a selection marker
(Ryan et al., 2014).
Here we employ CRISPR/Cas9 for introduction of DSB at genomic
targets and native homology-directed repair to integrate mutagenised
300–600 bp linear DNA donors to demonstrate a simple, yet eﬃcient,
method for directed evolution of enzymes in native genomic contexts.
We show that the method works for targeting single and double
genomic loci with equal eﬃciency, and also show that even mutation
distribution along the engineered fragment is maintained for the
genomic integrants. Finally, we apply the method for directed evolution
of two key metabolic enzymes in the mevalonate pathway of S. cerevi-
siae, thereby improving isoprenoid production by 11-fold. The method
is called CasPER, short for Cas9-mediated protein evolution reaction.
2. Materials and methods
2.1. Strains, plasmids and media
The yeast strains used here were isogenic to CEN.PK2-1C. Strains
and plasmids are listed in Supplementary Tables S1 and S2, respec-
tively. Yeast cells were grown in complete medium (YPD) with 2%
glucose and synthetic complete (SC) from Sigma, supplemented with
2% glucose. E. coli strains were propagated in LB medium supplemented
with 200mg of ampicillin.
All primer names and sequences are listed in Supplementary Table
S3.
2.2. Selection of gRNAs and plasmid construction
To select for speciﬁc gRNAs targeting BTS1, HMG2, ERG12 and
ERG20 we used the online CRISPy-web tool (Ronda et al., 2014). Se-
lected gRNA sequences corresponded as follows: BTS1 – TAGCTGCGA
TACAAGTTGCA; HMG2 – TGCTAGACATCTTCCCGGAT; ERG12 – GTT
AATAGGATCTAATGACT and ERG20 – CTATGAAGGAGTGCTTCTTT.
All gRNAs were expressed under SNR52 promoter and SUP4 termi-
nator, and the expression cassettes were USER cloned into cloning
vector pTAJAK-96 as previously described (Jakočiūnas et al., 2015a,
2015b). To construct the Cas9 expression plasmid, ﬁrst centromeric
pRS414 shuttle vector with the tryptophan selection marker (Sikorski
and Hieter, 1989) was ampliﬁed with primers TJOS-167F and TJOS-
167R to create USER cloning-compatible ends. Second, Cas9 expression
cassette (TEF1 promoter, Cas9 and CYC1 terminator) was ampliﬁed
from plasmid ID43802 (Addgene) using primers TJOS-168F and TJOS-
168R containing compatible USER cloning ends. Third, TEF1-Cas9-
CYC1 was USER cloned into previously prepared pRS414 shuttle vector
labelled pTAJAK-162. To create yeast strain TC-146 expressing Cas9,
pTAJAK-162 was transformed in to CEN.PK2-1C.
The carotenoid expressing strain was constructed as described pre-
viously (Ronda et al., 2015), herein labelled TC-100.
To reengineer the yeast strains with ERG12 and ERG20 mutant
variants, ﬁrst, ERG12–71 and ERG20–53 mutant variants were ampli-
ﬁed with primers TJOS-127F and TJOS-127R; TJOS-126F and TJOS-
126R respectively. Second, strain TC-146 was transformed either with a
single gRNA expression plasmid (targeting ERG12: pTAJAK-118 or
ERG20: pTAJAK-113) or with double gRNA expression plasmid
(ERG12+ERG20: pTAJAK-187) and previously ampliﬁed ERG12–71 -
ERG20–53 mutant variants, which served as donor templates for in-
tegration through homologous recombination and replacement of
original ERG12 or ERG20 or both. Newly constructed strains (TC-150:
ERG12::ERG12–71; TC-151: ERG20::ERG20–53; TC-152:
ERG12::ERG12–71, ERG20::ERG20–53) were used further to integrate
carotenoid genes and measure carotenoid production.
2.3. Mutagenesis and library preparation
First, templates for the error-prone PCR (epPCR) of the genes to be
engineered were designed with the PAM site mutated to prevent cutting
of the donor DNA, and subsequently ordered as biobricks (Integrated
DNA Technologies). The PAM site was mutated in such a way that the
obtained mutation would not change the native amino acid composi-
tion. Second, each biobrick served as a template for epPCR. The epPCR
was performed with the GeneMorph II Random Mutagenesis kit
(Agilent Technologies) using primers: BTS1 – TJOS-325F and TJOS-
325R; HMG2 – TJOS-323F and TJOS-323R; ERG12 – TJOS-124F and
TJOS-124R; ERG20 – TJOS-123F and TJOS-123R. Five consecutive
rounds of epPCR were performed by transferring 50–100 ng of DNA to
the next round of epPCR. The epPCR conditions were as follows:
° × ° − ° − °
°
s95 C–2 min .–30 [95 C–30 60 C–30s 72 C–1 min .]
–72 C–10 min
After 5 rounds of epPCR, the resulting DNA fragments (BTS1 or
HMG2) were pooled and puriﬁed by ethanol precipitation adding 3
volumes of 99% ethanol and 1/10 vol of 3M sodium acetate. As for
ERG12 and ERG20, after each round of epPCR, the resulting DNA was
puriﬁed by Nucleospin PCR cleanup kit (Macherey-Nagel). Further, the
DNA was treated with USER enzyme (New England Biolabs) according
to the manufacturer's instructions. Three USER treatment reactions
were performed with each puriﬁed epPCR reaction and transformed
into E. coli competent cells together with pTAJAK-71 (Jessop-Fabre
et al., 2016) previously digested with AsiSI (Thermo Fisher) and Nb.
BsmI (New England Biolabs) to create mutagenesis libraries. E. coli
transformants were plated on LB supplemented with ampicillin and
grown over night at 37 °C. Bacterial colonies were washed from the
plates and grown for plasmid extraction. Plasmids were extracted by
using Maxi prep kit (Qiagen).
2.4. Genome integration of mutagenized fragments
To integrate mutagenized fragments into the genome, yeast strain
TC-100 or TC-3 harbouring Cas9 expression vector was used.
Transformation with electroporation method (Wu and Letchworth,
2004) was performed with the following amounts of DNA:
5 picomoles of puriﬁed mutagenized fragments from each of the ﬁve
epPCR's (25 picomoles in total), for multiplex targeting 25 picomoles of
equally mixed BTS1 mutagenized fragments and 25 picomoles of
equally mixed HMG2 mutagenized fragments (50 picomoles in total);
for ERG12 and ERG20 engineering, each mutagenesis library was di-
gested with PvuII and fragments gel puriﬁed (25 picomoles in total for
each ERG12 and ERG20 were used); 10 μg of single or double gRNA
expression vector was used.
Mixed DNA needed for transformation was ethanol precipitated and
resuspended in 5 μL of water. BioRad MicroPulser electroporator with
settings for Fungi was used.
After transformation, cells were plated on SC (Sigma) plates or
propagated in liquid media by selecting for Cas9 and gRNA expression
vectors. Cells were propagated at 30 °C for 2–4 days.
2.5. Transformation eﬃciency quantiﬁcation
Transformation eﬃciencies were quantiﬁed by plating dilution
series on selective media and calculation the number of colonies
(Supplementary Fig. S1).
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2.6. Sequencing and analysis
To characterize the method, both BTS1 and HMG2 mutagenized
fragment libraries and genome integrants were sequenced. After pro-
pagation of yeast transformants in liquid media, the DNA from whole
cultures was extracted using ZR Fungal/Bacterial DNA miniprep kit
(Zymo Research). Both mutagenized fragments and genomic DNA were
used to generate amplicons of BTS1 and HMG2 as described by Lee and
colleagues (Lee et al., 2015) with the following primers: TJOS-339F and
TJOS-339R; TJOS-340F and TJOS-340R respectively. Amplicons were
sequenced by Illumina MiSeq using Nextera DNA library prep kit (Il-
lumina).
Initially raw fastq ﬁles where processed using the r package DADA2
to infer exact amplicon variants and their abundance (Callahan et al.,
2016). All additional analysis was performed in Jupyter-lab sing python
3.6.5 (Python Software Foundation, https://www.python.org/) and
BioPython (Cock et al., 2009), Pandas (McKinney et al., 2010), Mat-
plotlib (Hunter, 2007), numpy (Oliphant, 2015), mpmath (Johansson,
2013) and SciPy (Jones et al., 2001).
The analysis notebook and all raw data is available at https://data.
mendeley.com/datasets/wkd5wp9zwk/1.
In brief the analysis consists of the following: identify type and
number of mutants in detected variants compared to wild type and
visualize data in a number of ways. Count mutants per position and
visualize. Count speciﬁc mutation per position and visualize.
Count integration rate.
To evaluate if theres is a mutation frequency bias around the PAM
site we did the following: Fit a negative binomial (nb) to a histogram
representation of the mutation frequency per position along the am-
plicon. Then use the nb model to calculate how often you would see a
mutation frequency equal to, or higher, than the frequency observed
around the pam site (median of 5 bp window).
Furthermore, selected transformants from BTS1, HMG2, ERG12 and
ERG20 targets were Sanger sequenced with the following primers:
TJOS-15F and TJOS-15R (BTS1); TJOS-371F and TJOS-371R (HMG2);
TJOS-127F and TJOS-127R (ERG12); TJOS-126F and TJOS-126R
(ERG20).
2.7. Carotenoid extraction and quantiﬁcation
Five mL cultures were inoculated and grown at 30 °C for 72 h and an
equal amount of each culture (based on OD) was taken for further
analysis. Cells were collected by centrifugation and cell walls broken
using 0,5 mm glass beads (Sigma) and Precelllys 24 homogenizer
(Bertin Instruments). Intracellular carotenoids were extracted with
hexane.
In the pre-screen, carotenoid measurements were performed by
measuring the absorption at 449 nm with Implen spectrophotometer
(Implen). A standard curve was determined by measuring known con-
centrations of β-carotene and the following formula was used to
quantify carotenoids in the extracts (Verwaal et al., 2007):
Concentration of carotenoids = 25,509×A449mm − 0,5809.
For selected mutants, carotenoids (β-carotene and lycopene) were
quantiﬁed by HPLC. Diluted culture supernatants were held in the au-
tosampler at a temperature of 5 °C prior to analysis. The sample volume
injected was 10 μL and the separation was performed using a Supelco
Discovery HS F5-3 column (Sigma Aldrich), with a particle size of 3 µm,
i.d. of 2.1mm and a length of 15 cm. The column oven temperature was
set to 30 °C. Gradient elution was performed at a constant ﬂow rate of
0.7 mL/min using water with formic acid (1%) (eluent A) and acet-
onitrile (eluent B). The following gradient was applied: The initial
isocratic step with 25% eluent B (2min) was followed by an increase to
90% within 2min and kept for another 6.5 min. The column was re-
turned to initial conditions by decreasing eluent B for approx. 1min to
25% and remained at this value for another 2min. UV detection at
450 nm was applied for the quantiﬁcation of β-carotene and lycopene.
2.8. The methodological workﬂow
CasPER can be divided into the following major steps (Fig. 1). First,
a decision is made which DNA fragment is to be mutated. In our test
case we initially mutagenized fragments of 300-bp and 600-bp. Second,
a suitable gRNA is designed for the genomic target site(s) of interest by
the use of CRISPy (Jakočiūnas et al., 2015a), or similar gRNA design
tools, and a plasmid carrying gRNA expression cassette(s) for the
chosen PAM(s) is constructed. Third, 300-bp and/or 600-bp PAM-de-
ﬁcient DNA templates for mutagenesis are synthesized or ampliﬁed
from the host genome and processed through multiple rounds of error-
prone PCR (epPCR). The number of PCR rounds applied is reﬂected in
the number of mutations in the DNA fragment of interest (Cherry et al.,
1999). The epPCR is performed with primers containing 52-bp over-
hangs homologous to the genomic loci upstream and downstream of the
Cas9-mediated double-strand break (DSB). Overhangs may also include
a restriction site or a motif for cloning and generation of plasmid-based
mutagenesis library useful for propagation in E. coli and further use.
Fourth, mutagenized linear fragments together with the plasmid car-
rying the gRNA expression cassette are co-transformed by electro-
poration into the organism of interest.
Fig. 1. Schematic overview of experimental setup of CasPER method. CasPER is based on generation of mutagenized linear DNA fragments through repetitive rounds
of error-prone PCR (epPCR) and a standard yeast transformation together with gRNA expression plasmid for genome integration.
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3. Results
3.1. Characterization of CasPER for mutagenesis of genomic loci
As a proof-of-principle we applied the method in the yeast S. cere-
visiae in order to engineer a 300-bp catalytic domain of the non-es-
sential gene encoding geranylgeranyl diphosphate synthase (BTS1;
Fig. 2A) and a 600-bp region of non-essential gene encoding HMG-CoA
reductase (HMG2; Fig. 2B). To characterize the size and sequence
composition of integrated epPCR-derived donor fragments, we se-
quenced genomic amplicons from approximately 2000 colonies by next-
generation sequencing (NGS). This number of colonies was targeted to
get enough reads per colony-amplicon to overcome well-known NGS
error rates (Huang et al., 2012; Manley et al., 2016; Raymond et al.,
2017; Schirmer et al., 2015). The generated NGS data was analysed to
characterize the mutation landscapes of the genomic target loci and to
estimate the number of genome integrants at BTS1 and HMG2 genomic
loci compared to the mutation landscapes arising without the use of
Cas9-mediated DNA double-strand break (i.e. no gRNAs introduced).
First, since DNA double-strand breaks in yeast are primarily re-
paired by homologous recombination, the degree of sequence
homology at the termini of linear donor fragments is known to aﬀect
the frequency of insertional repair (Haviv-Chesner et al., 2007). To
evaluate if the method would support integration of linear fragments
mutagenized along the full length of the donor fragments, we mapped
all sequenced mutations across the 300-bp and 600-bp region and cal-
culated the frequency at which mutations occurred in a given position
(Fig. 2C-D; Supplementary Fig. S2). From this analysis, we observed
that mutations distribute evenly across both the 300-bp and 600-bp
regions with no overall bias towards higher mutation frequencies in
proximity to the DSB site (Fig. 2D-C; Supplementary Fig. S3). This is an
important observation when designing the genomic region to be tar-
geted (e.g. evolution of larger catalytic domains of enzymes).
Furthermore, sequencing revealed that, following standard trans-
formation procedure of S. cerevisiae, 98–99% Cas9-mediated integration
eﬃciency was observed for both BTS1 and HMG2 (i.e. all sequenced
colonies had at least one mutation integrated into the genomic site)
(Supplementary Table S4). Sequenced variants had up to twenty eight
Fig. 2. Characterization of CasPER for directed evolution of genes. (A) A schematic overview of experimental setup for engineering of BTS1, 300 bp fragment. (B) A
schematic overview of experimental setup for engineering of HMG2, 600 bp fragment. (C) Mutation landscape across 300-bp BTS1 fragment. Frequencies of mu-
tations for each nucleotide position are shown. Red line shows the position of double strand break (DSB) induced by Cas9. Purple and green rectangles indicate
unmutated homologous ends that were introduced as primers overhangs during epPCR for the eﬃcient integration to the homologous genomic site. (D) Mutation
landscape across 600-bp HMG2 fragment. Frequencies of mutations for each nucleotide position are shown. Red line shows the position of double strand break (DSB)
induced by Cas9. Purple and green rectangles indicate unmutated homologous ends that were introduced as primers overhangs during epPCR for the eﬃcient
integration to the homologous genomic site. (E) Number of mutations per 300 bp BTS1 fragment is shown in percentage of all sequenced transformants. (F) Number
of mutations per 600-bp HMG2 fragment is shown in percentage of all sequenced transformants.
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mutations when targeting BTS1 and up to twenty one mutations when
targeting HMG2, with a peak of one mutation per both 300-bp long
fragment and 600-bp long fragment (Fig. 2E-F). Further, as a control
experiment for the DSB-induced genome engineering eﬃciency, we
transformed the same amount of mutagenized fragments into yeast
expressing Cas9, but without co-transforming the gRNA expression
plasmid. Here, no mutagenized fragments were observed for BTS1 and
HMG2, conﬁrming that DSB caused by Cas9 is an essential feature of the
method (Fig. 2E-F).
Next, to characterize the eﬃciency of CasPER, we estimated the
total number of possible variants by calculating transformation eﬃ-
ciency when BTS1 and HMG2 are targeted. From this estimate we ob-
tained almost 2,4 million transformants when targeting BTS1 and al-
most 1,6 million transformants when targeting HMG2 (Supplementary
Fig. S1). Hence, since integration eﬃciency at both tested loci is
98–99% (Supplementary Table S4), the number of transformants ob-
tained is believed to be a reasonable proxy for estimating the number of
genomically integrated mutant fragments.
Biological systems are prone to genetic epistasis and synthetic
lethality (Mackay, 2014; Phillips, 2008). In order to uncover such re-
lationships and engineer genomes in higher throughput, genome en-
gineering methods should preferably support directed evolution of
more than one genomic locus per transformation. For this purpose, we
tested whether CasPER can enable the integration of mutagenized
linear fragments into two genomic loci in a single transformation. To
test this, we designed an experiment in which BTS1 and HMG2 were
targeted simultaneously using the same mutagenized 300-bp and 600-
bp DNA fragments as in single targeting experiment described pre-
viously (Fig. 3A). As for the characterization of the single locus edits
(Fig. 2C-F), we performed sequencing analysis to characterize the mu-
tation frequency and the mutation landscapes of the two genomic target
loci, when targeted in a single transformation. From this we observed
that the integration eﬃciencies of mutagenized fragments were were
identical to the eﬃciencies observed for singleplex targeting, namely
Fig. 3. Characterization of CasPER for directed evolution of genes in multiplex manner. (A) A schematic overview of experimental setup for engineering of BTS1
(300 bp) and HMG2 (600 bp) simultaneously. (B) Mutation landscape across 300-bp BTS1 fragment when targeted simultaneously with HMG2. Frequencies of
mutations for each nucleotide position are shown. Red line shows the position of double strand break (DSB) induced by Cas9. Purple and green rectangles indicate
unmutated homologous ends that were introduced as primers overhangs during epPCR for the eﬃcient integration to the homologous genomic site. (C) Mutation
landscape across 600-bp HMG2 fragment when targeted simultaneously with BTS1. Frequencies of mutations for each nucleotide position are shown. Red line shows
the position of double strand break (DSB) induced by Cas9. Purple and green rectangles indicate unmutated homologous ends that were introduced as primers
overhangs during epPCR for the eﬃcient integration to the homologous genomic site. (D) Number of mutations per 300 bp BTS1 fragment is shown in percentage of
all sequenced transformants. (E) Number of mutations per 600-bp HMG2 fragment is shown in percentage of all sequenced transformants.
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98% for BTS1 and 99% for HMG2 (Supplementary Table S4). As for the
mutation landscape along the 5’−3’ end of single donor fragments, we
again mapped all sequenced mutations across the 300-bp and 600-bp
region when both loci were targeted simultaneously (Fig. 3B–C;
Supplementary Fig. S4). Similar to our analysis of single genomic loci,
the mutation landscapes across the 300-bp and 600-bp regions showed
that mutations are evenly distributed without bias towards the DSB
(Fig. 3B–C; Supplementary Fig. S5). Additionally, sequenced variants
had up to twenty three mutations each when targeting both BTS1 and
HMG2, with a peak of one mutation for both 300-bp long fragment and
600-bp long fragment (Fig. 3D–E).
To characterise the eﬃciency of CasPER in multiplex manner, we
estimated the total number of possible variants by calculating trans-
formation eﬃciency when BTS1 and HMG2 is targeted simultaneously.
We obtained over 1 million transformats (Supplementary Fig. S1) with
integration eﬃciency of 98–99% (Supplementary Table S4), similarly to
what was observed for single site engineering.
To summarize, these results show that CasPER allows for eﬃcient
integration of large donor fragments into both single and multiple
genomic targets. Furthermore, the method is tolerant to genomic in-
tegration of donor fragments with multiple mutations without observed
biases along the donor regions. In comparison to other existing genome
engineering methods, CasPER is speciﬁcally useful when targeting
larger genomic regions, without sacriﬁcing engineering eﬃciency and
cost.
3.2. Application of CasPER for engineering key enzymes in yeast
mevalonate biosynthesis pathway
In order to investigate the potential of CasPER for directed evolution
of essential genes in their genomic contexts, we targeted two enzymes
in the mevalonate pathway, namely ERG12 and ERG20 (Fig. 4A).
Control of metabolic ﬂux through the mevalonate pathway is of para-
mount importance for prevention of various diseases (Akula et al.,
2016; Frenkel et al., 2000), and for the development of biobased pro-
duction of pharmaceuticals, food additives, fuels, cosmetics and others
(Ye et al., 2016). In yeast, ERG12 encodes the mevalonate kinase, re-
sponsible for phosphorylation of mevalonate, whereas ERG20 encodes
farnesyl pyrophosphate synthase, which catalyzes the formation of both
farnesyl pyrophosphate (FPP) and geranyl pyrophosphate (GPP), units
for sterol and isoprenoid biosynthesis (Chambon et al., 1991;
Oulmouden and Karst, 1990). It has been shown that FPP and GPP can
feedback inhibit binding of ATP to human mevalonate kinase, and
hence limit the production through the pathway further (Ruﬀ et al.,
2014).
We applied CasPER to mutate the 300-bp kinase catalytic domain of
ERG12, and the 600-bp catalytic domain of ERG20 (Fig. 4B, C). In order
to eﬃciently screen and select enzyme variants supporting improved
pathway ﬂux, we introduced a metabolic sink downstream from the
mevalonate and FPP pools, comprised of two heterologous carotenoid
biosynthetic genes crtYB and crtI from yeast Xanthophyllomyces den-
drorhous (Fig. 4A). When carotenoids are produced through this het-
erologous pathway, yeast transformants form yellow to orange colonies,
depending on the amount of carotenoids produced (Özaydın et al.,
2013; Verwaal et al., 2007). Hence, this pathway provides a facile vi-
sual screening platform to complement the high eﬃciency of CasPER.
Following transformation, approximately 60,000 colonies from each of
the two library transformations were plated. Next, approximately 200
colonies displaying a darker orange phenotype than the wild-type re-
ference strain were selected for further characterization (Fig. 4B, C).
Following colony replication and repeated scoring of the phenotype, a
pre-screen using spectrophotometric measurements of carotenoid ex-
tracts showed 1.5–3-fold higher carotenoid levels in 24 ERG12 and 11
ERG20 mutants (Supplementary Fig. S6). One of each of the ERG12 and
ERG20 mutants displaying darker orange phenotypes were selected for
further analyses. First, the selected mutants, ERG12–71 and ERG20–53,
were re-introduced into a wild-type strain replacing the native ERG12
and ERG20 genes. Both single and double mutant strains were
Fig. 4. Application of CasPER for engineering key enzymes in ergosterol biosynthesis pathway. (A) Schematic outline of the yeast mevalonate pathway: engineered
enzymes are depicted in red (ERG12), green (ERG20) and blue (BTS1). Carotenoid biosynthetic pathway is shown in orange rectangle and pathway genes written in
orange. (B) Overview of engineering and screening process for ERG12. (*) – marks WT colony. (C) Overview of engineering and screening process of ERG20. (*) –
marks WT colony. (D) Relative carotenoid measurements for wild-type and selected single and double mutants are presented together with visual colour phenotype of
the cells.
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constructed. Second, the carotenoid biosynthetic genes were introduced
to the single and double mutant strains, and carotenoid production was
quantiﬁed using HPLC. Carotenoid measurements showed an approx. 3-
fold higher production with the ERG12–71 mutant and a 5-fold higher
production with the ERG20–53 mutant, compared to the wild type re-
ference strain expressing the carotenoid biosynthetic genes (Fig. 4D). In
addition, the double ERG12–71/ERG20–53 mutant strain showed an
11-fold higher production of carotenoids when compared to a wild-type
reference strain (Fig. 4D).
Taken together, the application of CasPER for directed evolution of
ERG12 and ERG20 allows for simple and robust uncovering of improved
enzyme variants supporting increased ﬂux through the feedback regu-
lated isoprenoid pathway.
3.3. Mutant analysis of yeast mevalonate kinase and farnesyl
pyrophosphate synthase
To investigate the structural basis for increased carotenoid levels
supported by the ERG12 and ERG20 mutated enzymes we compared
them to homologs from other organisms and positioned the mutants
onto structural models. First, the sequence analysis of ERG12–71 and
ERG20–53 showed a single amino acid change at position 186 from
tryptophan to arginine for ERG12, and at position 95 from tyrosine to
serine for ERG20 (Supplementary Fig. S7). Second, we aligned the
primary structure of the ERG12 and ERG20 mutants with homologs
from mammals, plants, and other yeasts (Fig. 5A, B). Alignments
showed that tryptophan in position 186 of ERG12 is highly conserved
throughout the kingdoms and can play a role in enzyme structure
(Fig. 5A). On the other hand, tyrosine in position 95 of ERG20 is
Fig. 5. Mutant analysis of yeast ERG12 and
ERG20. (A) Amino acid sequence alignment of
S. cerevisiae WT ERG12, ERG12–71 and meva-
lonate kinases in species form plant, fungi and
mammalian kingdoms. Red box shows con-
served tryptophan at position 186 through
diﬀerent species and mutant 71 with trypto-
phan mutated to arginine (B) Amino acid se-
quence alignment of S. cerevisiae WT ERG20,
ERG20–53 and farnesyl pyrophosphate syn-
thases in species form plant, fungi and mam-
malian kingdoms. Red box shows conserved
tyrosine at position 95 through diﬀerent spe-
cies and mutant 53 with tyrosine mutated to
serine (C) Predicted 3D protein structure ofWT
ERG12 and ERG12–71 is shown. Tryptophan
position is depicted as well as ATP bound to
WT ERG12 is shown in upper panel. Arginine
position is depicted as well as ATP bound to
ERG12–71 is shown in lower panel. (D)
Predicted 3D protein structure of WT ERG20
and ERG20–53 is shown. Tyrosine position is
depicted as well as GPP/FPP bound to WT
ERG20 is shown in upper panel. Serine position
is depicted as well as GPP/FPP bound to
ERG20–53 is shown in lower panel.
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conserved in several fungi and plant species, yet diﬀerent from the
mammalian homologs, although, in mammals the tyrosine is replaced
with phenylalanine (Fig. 5B). Next, we analysed if the mutations in
ERG12 and ERG20 are causing structural changes to the enzymes. Since
the crystal structures for yeast ERG12 and ERG20 are not available, we
used SWISS-MODEL (Arnold et al., 2006; Biasini et al., 2014; Guex
et al., 2009; Kiefer et al., 2009) for the alignment of protein structures
based on known crystal structures from other organisms (Fig. 5C, D).
For the ERG12 structure alignment, the template 1kvk.1. A (Fu et al.,
2002) was used, which resulted in 32.71% sequence identity and pro-
duced global model quality estimation (GMQE) of 0.6. For the ERG20
structure alignment, the crystal structure of Gallus gallus FPP synthase
was used as a template (1ubw.1. A)(Tarshis et al., 1996). This resulted
in 47.65% sequence identity (GMQE = 0,77). We modelled 3D struc-
tures, both for wild-type ERG12 and mutant ERG12–71 (Fig. 5C) as well
as for wild-type ERG20 and ERG20–53 mutant (Fig. 5D). The mutations
in ERG12 and ERG20 do not visually inﬂuence the aligned 3D structures
of both enzymes. Further, it is worth mentioning that both mutations in
ERG12 and ERG20 are in close proximity to the ATP binding pocket of
the mevalonate kinase (Fig. 5C) and the GPP/FPP binding pocket of
farnesyl pyrophosphate synthase (Fig. 5D).
Finally, although our analysis does not provide a clear evidence to
how the mutations in ERG12 and ERG20 inﬂuence activity or structure
of the enzymes, it shows that the amino acids which were mutated are
conserved and are situated in close proximity to the ligand binding
pocket.
4. Discussion
In the last ﬁve years CRISPR/Cas9 has been used for genome en-
gineering and re-programing in yeast with eﬃciencies reaching 100%
(DiCarlo et al., 2013; Jakočiūnas et al., 2015a, b; Jensen et al., 2017;
Mans et al., 2015; Ryan et al., 2014) in both single and multiplex
manner, hence these advancements have revolutionised the way yeast
genomes are engineered today. Beyond the existing technologies,
CasPER is an eﬃcient method, which combines the generation of large
mutated DNA fragments by epPCR (or any other method for generating
sequence diversity) and multiplex genome integration of these frag-
ments by native HR machinery following targeted CRISPR/Cas9-medi-
ated DNA DSBs.
Indeed, CasPER has proven to be a very eﬃcient method, reaching
nearly 100% eﬃciency of integration of large mutagenised DNA frag-
ments in multiplex manner, and thereby allowing the generation of
millions of mutants from a single standard transformation. Importantly,
no signiﬁcant bias in mutation frequency was observed along integrated
donor fragments in relation to DSB proximity, allowing eﬃcient and
non-selective mutagenesis of large DNA fragments. As such, beyond the
proven eﬃciency of introducing donor variant libraries up to 600 bp
without the use of selection markers, this study also provides an in-
depth demonstration of the mutational landscapes and frequencies
which can be obtained surrounding CRISPR/Cas9-mediated DSB target
sites in HR-proﬁcient organisms like S. cerevisiae.
Further, in our study we hypothesized that CasPER can support the
integration of large donor variants encoding enzyme catalytic domains
or even whole coding regions of enzymes and other DNA regulatory
elements. To test this, we applied CasPER for directed evolution of
catalytic domains of two essential enzymes in the mevalonate pathway.
The experiment uncovered mutants that were able to improve car-
otenoid production by 11-fold, as a proxy for changed metabolic ﬂux
through yeast's native mevalonate pathway. Though this study did not
further characterize the biochemical activity of the evolved ERG12 and
ERG20 mutants, it is anticipated that these variants will be subject to
numerous follow-up studies and applications related to microbial pro-
duction of fuels and chemicals derived from the mevalonate pathway.
Finally, at present, most of the CRISPR/Cas9-based directed evolu-
tion methods rely on integration of relative small (80–120 bp) DNA
fragments (Barbieri et al., 2017; Garst et al., 2017; Guo et al., 2018) and
may require time-consuming construction of donor variant libraries
and/or relative costly DNA synthesis of diversiﬁed array-based oligos
(Nyerges et al., 2018; Roy et al., 2018). With CasPER, multiplex genome
engineering of larger genomic loci is now demonstrated at very high
eﬃciencies along the full size of donor fragment lengths, and should
thereby enable cost-eﬀective, high-throughput and robust evolution
studies of even complex multi-genic traits in any organism supporting
genome integration of heterologous DNA by homologous recombina-
tion.
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